Syncom Formulations (India) informs about certificate

05 Apr 2024 Evaluate

Syncom Formulations (India) has informed that it enclosed Certificate for Compliances as per Regulations 7(2) and 7(3) of the SEBI (LODR) Regulations, 2015 duly signed by the Compliance Officer and Company Secretary of the Company and Authorized Representative/Compliance Officer of the Share Transfer Agent -Ankit Consultancy of the Company for the Year ended on 31st March, 2024.

The above information is a part of company’s filings submitted to BSE.

Syncom Formulations Share Price

13.52 0.65 (5.05%)
01-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.20
Dr. Reddys Lab 1182.75
Cipla 1325.85
Zydus Lifesciences 878.80
Lupin 2138.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×